Chiozzini, C.; Manfredi, F.; Arenaccio, C.; Ferrantelli, F.; Leone, P.; Federico, M.
N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. Vaccines 2020, 8, 243.
https://doi.org/10.3390/vaccines8020243
AMA Style
Chiozzini C, Manfredi F, Arenaccio C, Ferrantelli F, Leone P, Federico M.
N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. Vaccines. 2020; 8(2):243.
https://doi.org/10.3390/vaccines8020243
Chicago/Turabian Style
Chiozzini, Chiara, Francesco Manfredi, Claudia Arenaccio, Flavia Ferrantelli, Patrizia Leone, and Maurizio Federico.
2020. "N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles" Vaccines 8, no. 2: 243.
https://doi.org/10.3390/vaccines8020243
APA Style
Chiozzini, C., Manfredi, F., Arenaccio, C., Ferrantelli, F., Leone, P., & Federico, M.
(2020). N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. Vaccines, 8(2), 243.
https://doi.org/10.3390/vaccines8020243